The University of Chicago Header Logo

Connection

Michael P Blair to Intravitreal Injections

Back to Details
This is a "connection" page, showing publications Michael P Blair has written about Intravitreal Injections.
Michael P Blair
Connection Strength
1.434
Intravitreal Injections
  1. Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
    View in: PubMed
    Score: 0.184
  2. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
    View in: PubMed
    Score: 0.171
  3. Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
    View in: PubMed
    Score: 0.165
  4. Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
    View in: PubMed
    Score: 0.164
  5. Re: Good: Bevacizumab for retinopathy of prematurity: treatment when pathology is embedded in a normally developing vascular system (Ophthalmology. 2016;123:1843-1844). Ophthalmology. 2017 10; 124(10):e74-e75.
    View in: PubMed
    Score: 0.153
  6. Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2017 03 01; 48(3):255-259.
    View in: PubMed
    Score: 0.147
  7. Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):280-3.
    View in: PubMed
    Score: 0.137
  8. Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec; 60(6):e75-e78.
    View in: PubMed
    Score: 0.058
  9. Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
    View in: PubMed
    Score: 0.047
  10. PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
    View in: PubMed
    Score: 0.040
  11. CONCURRENT SCLERAL BUCKLE AND INTRAVITREAL BEVACIZUMAB FOR ADVANCED RETINOPATHY OF PREMATURITY-RELATED RETINAL DETACHMENT. Retin Cases Brief Rep. 2016; 10(2):183-6.
    View in: PubMed
    Score: 0.034
  12. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization in ocular histoplasmosis. Retin Cases Brief Rep. 2014; 8(1):24-9.
    View in: PubMed
    Score: 0.029
  13. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS. 2013 Jun; 17(3):323-5.
    View in: PubMed
    Score: 0.028
  14. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
    View in: PubMed
    Score: 0.027
  15. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.
    View in: PubMed
    Score: 0.026
  16. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.